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Endovascular Treatment of Shunt-Induced Carotid Pseudoaneurysm:
Less Invasive but Still a Big Risk
Kuldeep Singh, MD, Danny Yakoub, MD, Jonathan Schor,MD, Jonathan
Deitch, MD, Jonathan Scheiner, MD, Christos Dossa. Staten Island Uni-
versity Hospital, Staten Island, NY
Objective: Carotid artery pseudoaneurysm (PSA) is a challenging
complication of carotid endarterectomy (CEA). We present a case and
literature review of post-CEA PSAs successfully treated percutaneously with
a covered stent.
Methods: A 57-year-old woman underwent a CEA of the left internal
carotid artery using patch closure and selective shunting using a Pruitt-Inahara
shunt. She was found to have a 3-cm incidental carotid artery PSA 3 months
later distal to the endarterectomized portion of the artery, the injury likely
resulting from the clamp or the balloon portion of the shunt. A percutaneous
5-mm 25-mmViabhan (Gore, Flagstaff, Ariz) covered stent was deployed to
successfully exclude the PSA. The patient suffered no complications. Follow-up
duplex imaging at 3 and 6 months and at 1 year confirmed PSA sealing and
patency of the internal carotid artery.
Results: A PubMed search of the topic found 15 patients (Table) with
post-CEA PSA treated with a covered stent. The results revealed the procedure
is technically feasible with acceptable patency rates, the longest being 9 years.
The procedure, however, caries a significant rate of periprocedural complica-
tions: one (7%) bleeding complication, four strokes (26%) and two deaths
(13%).
Conclusions: Endovascular repair of carotid PSA with a covered stent
can be successfully performed; however, high complication rates should be
considered before undertaking the procedure.
Review of literature on results of endovascular treatment of postoper-
ative carotid artery pseudoaneurysm using covered stents
Table.
Author/year
Age
(years) Sex
Etiology of
PSA Intervention Complications Follow-up
May, 1997 70 M Post CEA Wallgraft Embolic stoke during
deployment
US 6 months
Hertz,
2003 64 F Post CEA Wallgraft Fatal MI post-op —
Lin, 2003 74 M Post CEA Wallgraft None US 18 months
Terramani,
2003 82 M Post CEA Wallgraft Hematoma US 8 months
Baril, 2004 79 F Post CEA Viabahn None
Angiogram 12
months
McCready,
2004 58 M Post CEA Wallgraft
TIA during
deployment US 12 months
Grant, 2004 65 M Post CEA Wallgraft None US 1 year
Gupta,
2004 72 F Post CEA Viabahn None US 6 months
Jarrahnejad,
2005 79 M Post CEA Wallgraft Fatal stroke post-op —
Mousa,
2005 82 F Post CEA Wallgraft None US 6 months
Ahuja,
2007 70 M Post CEA Viabahn None US 18 months
86 F Post CEA Viabahn None US 12 months
Bigouri,
2007 76 M Post CEA Fluency Plus None US 3 months
Stein, 2007 77 F Post CEA Wallgraft None US 2 months
Troutman,
2010 66 M Post CEA Wallgraft None US 9 years
CEA, Carotid endarterectomy; PSA, pseudoaneurysm, TIA, transient
ischmic attack; US, ultrasound
Concomitant Carotid Bifurcation and Great Vessel Disease
Thomas J. Takach, MD, J. Michael Duncan, MD, James J. Livesay, MD,
David A. Ott, MD, Roberto D. Cervera, MD. Texas Heart Institute at St.
Luke’s Episcopal Hospital, Houston, Tex
Sponsored by Rabih A. Chaer, MD
Background: The management is unsettled and the prognosis ill
defined for patients with concomitant carotid bifurcation disease and great
vessel (GV) disease.
Methods: We analyzed operative outcomes, long-term patency, and
extended epidemiologic impact of the primary disease process in 80 consec-
utive patients (mean age, 63.3 years; 50.0% men) who presented with
symptomatic, concomitant carotid disease and GV disease. Each patient
underwent carotid endarterectomy (CEA; staged, n  21; simultaneous,
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n  70; total, n  91) and oncomitant GV reconstruction (one vessel, n 
54; multivessel, n  26). Simultaneous coronary artery bypass grafting was
performed in eight patients. CEA was staged (before GV reconstruction) for
contralateral concomitant GV disease (n 12); reversed staged after simul-
taneous, contralateral reconstruction for concomitant GV disease with bi-
lateral carotid disease (n  9); performed simultaneously with GV recon-
struction for unilateral, concomitant GV disease with (n  55) or without
(n  11) tandem carotid lesions; and performed simultaneously with GV
reconstruction and bilateral CEA for bilateral, symptomatic or preocclusive
carotid disease (n  2).
Results: Technical success was achieved in each patient. The 30-day
mortality rates were 2.9% (operative, 3 of 101) and 3.8% (patient, 3 of 80).
Stroke rates were 1.9% (operative, 2 of 101) and 2.5% (patient, 2 of 80).
Those outcomes included one fatal myocardial infarction and one nonfatal,
contralateral stroke, occurring after hospital discharge; one fatal respiratory
arrest, occurring 4 days after simultaneous, bilateral CEA and GV recon-
struction; and one fatal stroke, occurring after simultaneous, unilateral CEA
and GV reconstruction. Primary 10-year patencies were 96.5%  2.5% (GV
reconstruction) and 100.0% (CEA). Kaplan-Meier 10-year freedom from
specific events were any GV restenosis, 96.5% 2.5%; any carotid restenosis,
100.0%; death, 43.7%  9.0%; coronary revascularization, 59.7%  9.2%;
myocardial infarction, 68.2% 8.7%; stroke, 77.6% 10.3%; other vascular
procedure, 55.2%  8.4%; adverse cardiac outcome (death, myocardial
infarction, or coronary revascularization), 21.9%  7.0%; and adverse vas-
cular outcome (restenosis, stroke, or other vascular procedure), 48.7% 
8.1%.
Conclusion: An integrated approach designed to enhance cerebral and
myocardial protection may have contributed to the low morbidity and
mortality in this study while providing excellent long-term patency and
symptom relief. Incident, subgroup, and long-term outcome analyses illus-
trate the importance of complete revascularization; the potential risk of
simultaneous, bilateral CEA; the benefits of simultaneous, open reconstruc-
tion of tandem carotid lesions; the necessity of screening for concomitant
multivessel or multisystem disease; and the need for aggressive risk factor
modification in such patients.
Postoperative Myocardial Infarction Rate Is Not Increased for Carotid
Endarterectomy Under Local Anesthesia Compared to Carotid
Stenting
Elias Kfoury,MD, David Leng, MD, Homayoun Hashemi MD, Dipankar
Mukherjee, MD. Inova Fairfax Hospital, Falls Church, Va
Objective(s):Carotid artery stenting has been described as a minimally
invasive modality for carotid artery stenosis treatment since its introduction
in 1994. The CREST study came to establish carotid artery stenting as an
effective modality for treatment of carotid artery stenosis compared with
carotid endarterectomy, with a lower postoperative myocardial infarction
rate at the expense of postoperative stroke. Our study investigated the three
available modalities to compare the postoperative myocardial infarction rate
for carotid artery stenting compared with carotid endarterectomy in its two
modalities, general and local anesthesia.
Methods: A retrospective study was conducted at a large tertiary care
center for patients undergoing carotid artery stenting, carotid endarterec-
tomy under local anesthesia, and carotid endarterectomy under general
anesthesia. The 30-day postoperative myocardial infarctions and strokes
were evaluated for the different subgroups. Fisher exact test was used to
calculate the outcomes amongst the different modalities.
Results: The analysis included 1127 procedures, with 421 for carotid
endarterectomies performed under general anesthesia, 611 for carotid end-
arterectomies performed under local anesthesia, and 95 for carotid artery
stenting. Age distribution was not significantly different among the groups.
No significant difference in postoperative myocardial infarction was encoun-
tered between carotid artery stenting and carotid endarterectomy under
local anesthesia (0.2% vs 1.1%; P  .25). Carotid endarterectomy under
general anesthesia group had a significantly higher risk of myocardial infarc-
tion compared with the local anesthesia group (1.2% vs 0.2%; P  .44).
Conclusions: Our evidence suggests that carotid endarterectomy un-
der local anesthesia does not have an increased risk of myocardial infarction
compared with carotid artery stenting.
The ASTI Trial: Thirty-Day Primary End Point Results With Carotid
Artery Stenting Under Distal Protection in Surgical High-risk Patients
Koen Deloose,1 Marc Bosiers,1 Joren Callaert,1 Koen Keirse,2 Jürgen
Verbist,2 Patrick Peeters2. 1Department of Vascular Surgery, A.Z. Sint-
Blasius, Dendermonde, Belgium, 2Department of Cardiovascular and Tho-
racic Surgery, Imelda Hospital, Bonheiden, Belgium
Sponsored by Rabih A. Chaer, MD
Objective(s): The ASTI study (Adapt Monorail Carotid Stent System:
A Postmarket Clinical Follow-up Study) is a prospective, single-arm, multi-
center, multinational, monitored trial conducted at 11 hospitals in Belgium,
Germany, and Spain. The trial objective is to evaluate the safety and
effectiveness of carotid artery stenting in patients at high risk for endarter-
ectomy who require carotid revascularization to treat extracranial carotid
stenosis.
Methods: The device used in the trial was the Adapt Monorail Carotid
Stent, used in conjunction with the FilterWire EZ Embolic Protection
System. The primary end point was the composite rate of major adverse
events (MAE), defined as death, stroke, and myocardial infarction at 30 days
postprocedure and adjudicated by an independent Clinical Events Commit-
tee.
Results: Of the 100 patients enrolled, 32 (32%) presented with a
symptomatic carotid lesion and 63 (63%) were asymptomatic. Four patients
(4%) were not classified by symptomatic status and one (1%) was not treated
with the Adapt Stent System. The 30-day follow-up results were available for
92 patients. The 30-day composite MAE rate (death, stroke, myocardial
infarction), as adjudicated by an independent Clinical Events Committee,
was 5.4%, comprising a 30-day major stroke rate of 2.2% and a 30-day minor
stroke rate of 3.2%. All MAEs in the ASTI trial were ipsilateral strokes. All
major strokes were hemorrhagic, and all minor strokes were ischemic in
nature. No deaths or myocardial infarctions were reported.
Conclusions: Use of the Adapt Carotid Stent with the FilterWire EZ
produced a low and acceptable rate of MAEs (5.4%) through 30 days
postprocedure. Results from ASTI suggest that carotid artery stenting with
embolic protection, is, in general, a safe alternative to CEA for patients with
high surgical risk.
Left Main Coronary Artery Disease as a Predictor of Concomitant
Carotid Artery Disease
Michael Shih, David Slovut, Yana Etkin, Evan Lipsitz. MontefioreMedical
Center, Albert Einstein College of Medicine, Bronx, NY
Objective(s): Previous studies have suggested that the incidence of
carotid stenosis in patients with left main coronary disease is higher than in
the general population and in patients with coronary artery disease without
left main disease. This study was conducted to compare the incidence of
carotid stenosis in patients undergoing cardiac surgery with and without left
main disease at our institution.
Methods: A retrospective review of all patients undergoing coronary
artery bypass grafting with and without left main disease was performed from
2009 to 2011. Patients with and without left main disease were compared.
Peak systolic velocities, end diastolic velocities, and internal carotid/com-
mon carotid ratios were recorded for both groups. Carotid stenosis was
classified as 50% to 69% when peak systolic velocities 160, 70% to 89%
when the internal carotid/common carotid ratio 4, 90% if end diastolic
velocities 100, and 100% for total occlusion. Statistical analysis was per-
formed with the Fisher exact test.
Results: Of the 399 patients with left main disease, 274 underwent
carotid duplex imaging looking at 547 vessels. The control group consisted
of 303 patients with 600 carotids evaluated. In those being treated for left
main disease, 60 of 547 vessels (11.0%) had 50 stenosis, whereas in the
control group, 41 of 600 vessels (6.8%) were positive (P  .016). Most
patients with carotid stenosis had moderate disease (50% to 69%), 44 of 547
(8.0%) in the left main group vs 23 of 600 (3.8%) in the control group (P
.003). The incidence of high grade stenosis (70%) and occlusion were
comparable in both groups.
Conclusions: In our population, left main coronary disease was a risk
factor for concurrent carotid artery disease. Of those, most had moderate
stenosis. Further studies are needed to further delineate the clinical rele-
vance, associated factors, and appropriate treatment for these patients with
both carotid and coronary disease.
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